Search for a trial

OPTImaL: Optimisation of treatment for patients with low stage triple-negative breast cancer with high sTIL

To assess whether adjuvant chemotherapy can be safely omitted in patients with pathological stage I (pT1a/b/cN0) TNBC and a high sTIL score (defined as >=50% for patients <40 years at the time of TNBC diagnosis; >=75% for…